Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
CS Constantinescu, N Farooqi… - British journal of …, 2011 - Wiley Online Library
Experimental autoimmune encephalomyelitis (EAE) is the most commonly used
experimental model for the human inflammatory demyelinating disease, multiple sclerosis …
experimental model for the human inflammatory demyelinating disease, multiple sclerosis …
Construction of tissue engineered nerve grafts and their application in peripheral nerve regeneration
Surgical repair of severe peripheral nerve injuries represents not only a pressing medical
need, but also a great clinical challenge. Autologous nerve grafting remains a golden …
need, but also a great clinical challenge. Autologous nerve grafting remains a golden …
Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6
RH Lee, AA Pulin, MJ Seo, DJ Kota, J Ylostalo… - Cell stem cell, 2009 - cell.com
Quantitative assays for human DNA and mRNA were used to examine the paradox that
intravenously (iv) infused human multipotent stromal cells (hMSCs) can enhance tissue …
intravenously (iv) infused human multipotent stromal cells (hMSCs) can enhance tissue …
Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology-a systematic review
R Klopfleisch - BMC veterinary research, 2013 - Springer
Background Histopathology has initially been and is still used to diagnose infectious,
degenerative or neoplastic diseases in humans or animals. In addition to qualitative …
degenerative or neoplastic diseases in humans or animals. In addition to qualitative …
[HTML][HTML] The multifaceted role of astrocytes in regulating myelination
H Kıray, SL Lindsay, S Hosseinzadeh… - Experimental neurology, 2016 - Elsevier
Astrocytes are the major glial cell of the central nervous system (CNS), providing both
metabolic and physical support to other neural cells. After injury, astrocytes become reactive …
metabolic and physical support to other neural cells. After injury, astrocytes become reactive …
[HTML][HTML] Is multiple sclerosis a mitochondrial disease?
P Mao, PH Reddy - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2010 - Elsevier
Multiple sclerosis (MS) is a relatively common and etiologically unknown disease with no
cure treatment. It is the leading cause of neurological disability in young adults, affecting …
cure treatment. It is the leading cause of neurological disability in young adults, affecting …
Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery
CD Porada, G Almeida-Porada - Advanced drug delivery reviews, 2010 - Elsevier
Mesenchymal stem cells (MSCs) possess a set of several fairly unique properties which
make them ideally suited both for cellular therapies/regenerative medicine, and as vehicles …
make them ideally suited both for cellular therapies/regenerative medicine, and as vehicles …
Neurotrophic factors as regenerative therapy for neurodegenerative diseases: current status, challenges and future perspectives
Y El Ouaamari, J Van den Bos, B Willekens… - International journal of …, 2023 - mdpi.com
Neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD),
Huntington's disease (HD), multiple sclerosis (MS), spinal cord injury (SCI), and amyotrophic …
Huntington's disease (HD), multiple sclerosis (MS), spinal cord injury (SCI), and amyotrophic …
Ciliary neurotrophic factor (CNTF): New facets of an old molecule for treating neurodegenerative and metabolic syndrome pathologies
S Pasquin, M Sharma, JF Gauchat - Cytokine & growth factor reviews, 2015 - Elsevier
Ciliary neurotrophic factor (CNTF) is the most extensively studied member of the cytokine
family that signal through intracellular chains of the gp130/LIFRβ receptor. The severe …
family that signal through intracellular chains of the gp130/LIFRβ receptor. The severe …
Optimizing mesenchymal stem cell-based therapeutics
Mesenchymal stem cell (MSC)-based therapeutics are showing significant benefit in multiple
clinical trials conducted by both academic and commercial organizations, but obstacles …
clinical trials conducted by both academic and commercial organizations, but obstacles …